Product
Standard Prophylaxis
1 clinical trial
2 indications
Indication
Acute Graft Versus Host DiseaseClinical trial
Sitagliptin Efficacy and Safety for Prevention of Acute Graft Versus Host Disease in Patients Receiving Alternative Donor Allogeneic Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2023-05-01